Bulluck Heerajnarain, McEntegart Margaret
Yorkshire Heart Centre, Leeds Teaching Hospital NHS Trust, Leeds, UK.
West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, UK.
JRSM Cardiovasc Dis. 2022 Apr 5;11:20480040221089760. doi: 10.1177/20480040221089760. eCollection 2022 Jan-Dec.
With the aging population, up to a third of patients referred for percutaneous coronary intervention (PCI) have moderate or severe calcified lesions assessed by coronary angiography. The presence of coronary calcium is associated with difficult device delivery, sub-optimal stent deployment, and prolonged procedures, with more complications. Furthermore, it is known that sub-optimal stent expansion is associated with poor clinical outcomes. In this manuscript we describe how to quantify the severity of coronary calcium, review the armamentarium of contemporary devices available for calcium modification, and provide a systematic approach to device selection, assessment of successful calcium modification, and stent optimization.
随着人口老龄化,在接受经皮冠状动脉介入治疗(PCI)的患者中,高达三分之一经冠状动脉造影评估有中度或重度钙化病变。冠状动脉钙化的存在与器械输送困难、支架植入不理想、手术时间延长及更多并发症相关。此外,已知支架扩张不理想与不良临床结局相关。在本手稿中,我们描述了如何量化冠状动脉钙化的严重程度,回顾了可用于钙化处理的当代器械,以及提供了一种器械选择、评估钙化处理是否成功及支架优化的系统方法。